Similar articles

• Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

  Howell SB, Pfeifle CE, Wung WE, Olshen RA. Howell SB, et al. Cancer Res. 1983 Mar;43(3):1426-31. Cancer Res. 1983. PMID: 6681730
• Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.

  Canal P, de Forni M, Chatelut E, Chevreau C, Johnson NP, Houin G, Bugat R. Canal P, et al. Acta Med Austriaca. 1989;16(3-4):84-6. Acta Med Austriaca. 1989. PMID: 2609919
• [Effect of sodium thiosulfate on the anti-tumor effect and nephrotoxicity of CDDP in human gastric cancer].

  Saito D, Fujii T, Yoshida S, Ohkura H, Oguro Y. Saito D, et al. Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 2):959-63. Gan To Kagaku Ryoho. 1990. PMID: 2188616 Review. Japanese. No abstract available.
• "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.

  Kobayashi H, Hasuda K, Aoki K, Kuroiwa T, Taniguchi S, Baba T. Kobayashi H, et al. Cancer Chemother Pharmacol. 1989;24(3):141-7. doi: 10.1007/BF00300233. Cancer Chemother Pharmacol. 1989. PMID: 2736707
• Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.

  Gandara DR, Wiebe VJ, Perez EA, Makuch RW, DeGregorio MW. Gandara DR, et al. Crit Rev Oncol Hematol. 1990;10(4):353-65. doi: 10.1016/1040-8428(90)90010-p. Crit Rev Oncol Hematol. 1990. PMID: 2177606 Review.